Schedule 13G ownership disclosure

LAKEFRONT BIOTHERAPEUTICS NV

Security class unavailable · CUSIP: 36315X101

Event date: 2018-11-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,400,228
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-069741
Form type
SC 13G/A
Filer
Lakefront Biotherapeutics NV
CIK
CIK 1421876
Filed
Nov 23, 2018
Reporting period
Nov 20, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub